Increasing research and development activities in the pharmaceutical and biotechnology industries are driving the growth of the animal model market. Animal models are crucial for studying diseases, drug discovery, and development, which is fueling the demand for these models.
The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is also a major growth driver for the animal model market. Animal models play a crucial role in understanding the disease mechanisms, testing new therapeutics, and evaluating treatment efficacy, thus driving the market growth.
Advancements in genome editing technologies, such as CRISPR-Cas9, are enabling researchers to create more precise and genetically modified animal models for studying various diseases. This technological advancement is boosting the demand for animal models in research and development activities, further driving market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Animal Type, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences,, Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, BIOCYTOGEN, BioSpherix,. |
Stringent regulations and ethical concerns regarding the use of animals in research are major restraints for the animal model market. Regulatory bodies are imposing strict guidelines for the ethical treatment of animals used in research, which can limit the availability and use of animal models in studies.
High costs associated with the maintenance and care of animal models are also a significant restraint for the market. The expenses involved in housing, feeding, and monitoring animals can be substantial, especially for large-scale research projects, which can hinder the adoption of animal models in research activities.